Lunai Bioworks (NASDAQ: LNAI) Launches National Chemical Defense Consortium Targeting $400M-$1.2B U.S. Countermeasure Programs; 3-Year AI Antidote Development Model

Stocks recover from war shock as Wall Street sniffs a turning point

XRP Treasury Evernorth Files SEC Form S-4 for Nasdaq Listing

S&P 500 breaks below its 200-day MA and hits a 4-month low as yields pop

Wall St falls as oil surge stokes inflation fears; Russell 2000 slips

U.S. stocks have reached a critical line in the sand. Why the next move could be a 10% drop.